Skip to main content
IMB 26.1400 GBP +5.06%
IMB · IMPERIAL BRANDS PLC
26.1400 GBP +1.2600 (+5.06%) At close · Oct 8
Market Cap
18.69B GBP
Shares
751.20M
All webcasts

Earnings call · FY2026 Q2

IMPERIAL BRANDS PLC (IMB) Q2 2026 Earnings Call Transcript

Concluded May 12, 2026 Audio replay
May 12, 2026 1:01:20 0 turns
Period
FY2026 Q2
Runtime
1:01:20
Sources
2 artifacts

Listen to the call

Audio replay & transcript

Play the captured call or open the complete transcript.

1:01:20 Audio

Half-Year Results

Tuesday, 12th May 2026

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Cautionary Statement

Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company’s future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forward-looking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forward-looking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for, the members of the Company, as a body, and no other persons. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

2

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Introduction John Crosse Head of Investor Relations, Imperial Brands Introduction Hello, good morning, everyone. Thanks for joining us for our half-year '26 results. Just a few housekeeping items before we kick off. For those of you in the room, there are no planned fire alarm tests today. So, if it goes off, it is a real one. You'll see the fire exit is just behind you there, lit up in green. Slide - Disclaimer And finally, I just wanted to draw your attention to the usual disclaimer in our RNS this morning and in the presentation, which we're just about to go through. So, without further ado, I'll hand over to Lukas.

Results Overview Lukas Paravicini CEO, Imperial Brands Welcome Thank you very much, John.

Good morning and a very warm welcome to this results

presentation. Thank you very much for joining us here in the room, and a very warm welcome to those who join us online. Slide - Agenda Today, I'm joined by Murray McGowan, our Chief Financial Officer, and John Crosse, our Director for Investor Relations. Murray and myself really look forward to presenting the first six months of our fiscal year '26 and also the first six months of our Evolve 2030 strategy. I'll start off with a few highlights. Murray will then take the stage and talk us through the financial performance and our expectation for the full year. I will then come back on stage and discuss in more detail how we are still delivering strong operational performance, while at the same time delivering self-help efficiencies and transforming our business to deliver long-term sustainable growth. With that, let me start the presentation. Slide - Another Half of Consistent Delivery Positive start to FY26 and implementation of 2030 strategy There are four overarching points which Murray and I want to make in today's presentation. First, our consistent financial performance continues to deliver growth in net revenue and adjusted operating profit, driving cash generation of £2.6 billion over the past 12 months. This is underpinning consistent capital returns, which includes our “evergreen” share buyback. Second, the progress we have made in the first half means we are well-placed to deliver on our expectation for the full year, and we confirm the guidance we've previously given. 3

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Third, our strategic progress and operational delivery continues to be underpinned by our distinctive challenger approach, which is a source of sustainable competitive advantage. As you've heard us say before, this challenger mindset is about deep insights into our consumers, a laser focus on the key drivers of growth and investing in agility, so we can create more sustainable value in combustibles and build scale in NGP. Fourth, over the past six months, we have made significant progress in the strategic transformation of our business. These activities are delivering material efficiencies in the shortterm and building capabilities that will unlock long-term growth, helping us become an even stronger challenger business. Slide - Half-Year Delivery Driving Shareholder Returns So, let's look first at our half-year dashboard.

In the centre, you can see how operating

performance is supporting top-line revenue growth and growth in earnings per share. We are on target to deliver our full-year objective of at least high single-digit growth in EPS. This is enabling sustainable capital returns shown on the right. We have announced a 4% increase in the ordinary dividend, and we are on track with our £1.45 billion share buyback. Now, I recognise that at the half-year point, the two numbers on the left will be a focus for some of you. Looking at the market share, the aggregate figure of our five priority markets is lower. This reflects a deliberate choice to prioritise value over low-return volume. In NGP, where we have grown share and volumes in all categories, overall revenue growth is below our full-year guidance of double-digit.

This is due to one-off factors, particularly the timing of

promotions over the year-end in the US, which we do not expect to repeat. When I come back, we will get into the detail of what sits behind these numbers, and we will highlight the underlying strengths of our operations and our positive trajectory for the second half. Slide - Perform and Transform Evolving the distinctive challenger approach While staying focused on delivering our fiscal year '26 commitments, we are also making purposeful progress on our strategic transformation.

We are performing, and we are

transforming, and we are delivering our in-year plans.

At the same time, we are making

progress on self-help efficiencies and developing the capabilities to enable sustainable longterm growth. On this slide, you can see how we are moving forward on our strategic priorities across the top of the wheel, strengthening our combustible business and NGP business. We have also achieved key milestones in our strategic enablers, which you can see on the bottom half. These are activities which either immediately and materially reduce our cost base or underpin long-term growth through improved technology, processes and consumer capabilities. When I come back, I will get into the detail of the actions we are taking, and how they are already supporting delivery against the financial commitments we made last year at our Capital Markets Day. With that, I would like to hand over to Murray for him to take us through the financial performance and our expectation of the full year. Murray, over to you.

4

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Financial Review & Outlook Murray McGowan CFO, Imperial Brands Slide - Continued Financial Delivery Sustaining strong capital returns Thank you, Lukas and good morning, everyone. The past six months has been a period of broad-based growth. We delivered growth in our tobacco and NGP net revenue, growth in combustibles through pricing to offset volume declines, and growth in NGP through strong volumes and share gains across all three categories, underpinning improvement in net revenue as we build scale. Our Group adjusted operating profit growth of 0.6% reflects this, but also some headwinds in the US and Australia, which I'll come on to later. We've delivered £2.6 billion of free cash flow on a 12-month basis. Leverage at 2.4x was higher than the full year for the usual seasonal reasons, but it remains within our target range and flat year-on-year. Overall, we are on track to deliver against our plan for this fiscal year and meet our capital allocation priorities. Slide - Tobacco Price Mix Offsetting Volume Declines Growing tobacco net revenue across all regions These results are another good illustration of the tobacco value model in action. Strong pricing across our footprint, shown here in orange, more than offset volume declines, shown in grey, to deliver low single-digit tobacco net revenue growth in line with guidance. In Europe, our largest region, pricing of 6% outpaced volume declines. In the US, pricing of 5.7% was driven by pricing both in the cigarette and mass market cigars portfolios. In AAACE, volume growth reflects entry into new markets. Excluding Australia, AAACE delivered 6.1% price mix, similar to Europe and the US. Slide - Growing Adjusted Operating Profit Performance to be weighted to the second half as guided Tobacco operating profit growth was driven by strong performance in Europe, which grew 6.5%, and in AAACE, excluding Australia, which grew 10.8%. In the US, growth in combustibles was offset by some one-offs, which I'll cover in the next slide. Whilst NGP losses increased slightly, this reflects the impact of Zone promotional activity in the US over the prior year-end, which was more successful than we anticipated and was recorded in H1. This reduced NGP net revenue and increased NGP losses by around £13 million. Without this, US NGP net revenue growth would have been positive. At a Group level, NGP net revenue growth would be double-digit and total NGP losses would have reduced in H1 year-on-year. It was also pleasing to see Europe NGP make a profitable contribution during the first half. Adjusted operating profit from Logistics declined, reflecting a reduced profit from tobacco inventory, which offset underlying growth in the business.

As we said back in November,

performance will be weighted to the second half, and I'll explain some of those drivers next.

5

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Slide - Adjusted Operating Profit One-offs Reduced impact in H2 supports improved performance and FY delivery This slide shows some of the one-offs impacting H1 performance. In combustibles, these were in the US and in Australia. In the US, tariffs on our mass-market cigars were a drag, but given the changes to tariffs following the Supreme Court decision in February, this impact will reduce in H2. We'll also see the full impact of pricing taken on MMC during the course of H1 support our H2 delivery. In Australia, we have seen accelerated volume declines of around 50%, which have impacted on AOP. There'll be less of a drag year-on-year in H2 as we annualise those volume decreases and expect adjusted operating profit to stabilise. We will also see a benefit from the actions taken in the first half to resize and refocus our operations in Australia. We're driving growth through white space market entries, most notably in Syria, which are making a meaningful contribution, and which will drive further growth in the second half. In NGP, we had the impact of the promotional activities in the US that I mentioned earlier. Given our clear focus on modern oral in the US, we've taken the decision to transition out of the US vapour category. This move will help to reduce NGP losses in H2. As a reminder, our US vape proposition, our legacy myblu device, first launched almost a decade ago, makes a small and declining contribution to revenue. So, we expect a stronger NGP performance in H2 in both net revenue and AOP growth. Altogether, these one-offs had an impact of over £50 million in H1. This will be much reduced in H2, as I've explained. So, this, combined with usual benefits of price and operational gearing, means that we are confident of a step-up in performance in H2 and remain committed to our previous full-year guidance. Slide - Operating Profit: Adjusting Items 2030 strategy costs and Delaware comprise majority of adjustments Now, as CFO, I want to ensure we're always transparent about items that we classify as adjustments. Today, we're disclosing charges related to our 2030 strategy and historical legal cases. Charges related to our 2030 strategy are in line with guidance that we gave at our Capital Markets Day back in March 2025 and relate to the rationalisation of our manufacturing footprint and our transformation programme. This includes our exit from Langenhagen. We'll start to see the benefits from this and the recently announced sale of our Taiwan factory coming through in the second half. We have hit the ground running in our long-term partnership with Capgemini. In the second half, we'll start to accrue the benefits of this new partnership. Lukas will discuss these in more detail later. Our transformation is ongoing and remaining costs will be adjusting items in future years. We also showed charges related to the settlement of the Delaware case. All historical charges have been adjusted out. Cash costs will be reflected in our free cash flow in line with the payment schedule agreed.

As a reminder, that's £150 million in H1 this year, then the

remaining £162 million in roughly equal instalments over the next three years.

6

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Slide - Delivering Continued EPS Growth Operating profit growth and share count reduction, offset by interest Our adjusted EPS reflects our operating profit growth, and the reduced share count due to our ongoing share buyback. An increase in finance costs was offset by lower tax and minority interest charges. The adjusted effective tax rate at 23.5% remained flat on the same period a year ago. Slide - On Track with FY26 Capital Allocation Strong free cash flow supporting shareholder returns Turning to cash and capital allocation. Our operating cash conversion was 98% on a 12-month basis, reflecting our continued focus on working capital. Our cash flow performance compares well versus prior years. Disciplined capital allocation remains a key part of how we create value. Leverage at the halfyear remained flat year-on-year, and we're on track to be around the lower end of our target range at year-end. We've announced a 4% increase in our ordinary dividend, and we're on track with our £1.45 billion share buyback.

This is our fourth consecutive year of share

buybacks and brings the total capital return to investors since the programme started to £4.8 billion. Taken alongside dividend payments, total cumulative capital returns from FY21 to halfyear '26 now sit at £11.5 billion. This represents around 77% of our market capitalisation at the time of Capital Markets Day back in January 2021. To remind you, as we stated at Capital Markets Day in March 2025, we are committed to an evergreen always-on share buyback throughout this five-year strategic period. Slide - Maintaining Full-year Guidance H2 weighted as previously guided So, to close my section, we maintain our full-year guidance. We continue to expect full-year tobacco net revenue growth in the low single digits and double-digit NGP net revenue growth. Adjusted operating profit growth will be within our mid-term growth range target of 3-5%. We expect at least high single-digit EPS growth for the full-year period, supported by profit growth and the ongoing share buyback, all at constant currency. We expect at least £2.2 billion of free cash flow, including the impact of cash costs related to the Delaware settlement and the implementation of our 2030 strategy. On the Middle East, our position is similar to where it was when we issued our trading statement last month. We have not seen a material impact from the crisis in the Middle East to date. Clearly, the longer the situation persists, the more likely there could be a meaningful impact on input costs and consumer demand, including duty-free.

Now, our business has proven its

resilience during past crises. We've managed through them before, and if necessary, we will take mitigating actions. At current rates, we expect foreign exchange to be a headwind of 0-1% to operating profit and EPS growth. As usual, there's a slide in the appendices with guidance on specific items. We also remain committed to the medium-term guidance we set out at our CMD in March 2025. This means we remain well-placed to generate long-term value for our shareholders. Thank you. I'll now hand back to Lukas, who will give an update on operational performance. Lukas. 7

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Operational and Strategic Update Lukas Paravicini CEO, Imperial Brands Slide - Our Evolved Strategy Building on the strong foundations from the last five years Thank you very much, Murray. What I want to do in this section is take you through our strategy, shown here on the wheel. I will explain how, just six months into this five-year strategic period, we've already made rapid progress. We are performing today. We are delivering significant self-help efficiencies, and we are transforming to a more efficient way of doing business. We are doing this to unlock longterm growth. I'm going to start with the segment on the top left and talk about how we are creating sustainable value in combustibles. Slide - Balancing Share and Value in Priority Markets Not all points of market share are equal Here, we're carefully balancing the triangular equation of price, volume, and share. In each of our regions, as you saw, pricing has once again more than offset volume declines.

In the

majority of markets, tobacco continues to be affordable. The tobacco value creation model is working well. Looking at the left of this slide, we're comfortable with how each of the individual priority markets has delivered. The US and Spain have been executing with discipline, focussing on winning the more valuable segments while pricing responsibly in the lower price segments to maximise sustainable value. Germany has delivered a great performance in what is an intensely competitive market. And as a reminder, our UK and Australia teams who operate in declining markets are tasked with prioritising value over volume and share. So, in that context, a 16basis point aggregate share reduction in a given period is consistent with running the business for sustainable value creation. Before we move to the right-hand side, let me make a few further points about how we see market conditions evolving, and the implication for how we approach market share. As we said at last year's CMD, share is important. We will not return to the period before 2020, when we were consistently the industry number one share donor. Across all our major markets, pricing ladders are becoming more stretched. This means the gap in industry gross margin between the premium segment and the deep discount is growing. It's a simple point, but it's worthwhile emphasising: not all basis points of market share are equal. These evolving market dynamics are requiring us as a challenger business to fine-tune how we manage our portfolio to take a more focused segment-by-segment approach. On the right, you can see the significant and growing difference in the gross margin per thousand sticks that we can achieve at the top of the price ladder versus the discount segment. In the US, Germany and Spain, this widening spread means it is increasingly important for us to double down on premium segments, while,, of course, maintaining a strong presence at the discount end of the market. 8

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

So, in each market, we focus on nurturing our premium brands, aiming to grow our share of that segment. At the same time, we seek to achieve the right balance of price and volume in the discount segment to deliver sustainable value over the long term for shareholders. Slide - US: Strong Combustibles Business High affordability, pricing offsetting volume declines In line with this approach, in the US we have been operating with discipline in a market which has seen growth in the deep discount segment and new brand launches. As I mentioned, we have been successfully defending our premium brands, Kool and Winston, and expanding our share of that segment. And in deep discount, Crowns continues to take share, but we have been mindful in balancing price with segment share, given the increased competitive intensity. We have also launched a new brand, Malibu, which is enabling us to take more pricing on other brands. It is another lever for us to balance the volume and value equation. Our cigar business also continues to perform well, with Backwoods gaining segment share and delivering strong revenue growth. Slide - Priority Markets: Balancing Value and Share Market-specific approach Our other priority markets have been playing the individual roles we ascribed to them in our 2030 strategy. In Germany, the market remains highly attractive, with a good performance in cigarettes, with growth in both the premium and discount segments. In Spain, which had a low market volume decline of only 2% in H1, the focus is again on value. The UK is maximising value in combustibles, while growing share in vape and modern oral, and the Australian team continue to find opportunities in what, as you all know, is a challenging market. Slide - NGP: Following a Multi-Category Approach Building scale across all categories Now, turning to NGP. Since rebooting our NGP business five years ago, we have established clearly focused brands and products. Across all three categories, once again, we have grown share. And as we build scale, we are seeing attractive gross margins. Our approach to market entry remains consistent. We will enter markets only where the category has been created and where we have an existing route to market. Slide - US OND: Investment Driving Category Growth Zone continues to deliver strong volume and share growth Our launch into the US OND market is a good example of this challenger approach. We launched our Zone brands just over two years ago, and we are really pleased with the performance. This is a fast-growing but still nascent category, which is now around 10% of the legal nicotine market. The industry is investing significantly to grow the category and build brands with heightened promotional activity and trialling. This is the normal thing you expect to see market leaders doing in order to create long-term value. But what this means is in the short term, volume will grow well ahead of value. Within this industry context, we are applying our challenger mentality by being choiceful and agile in our approach. Our focus is on patiently growing volume share by building differentiated brands through consumer activation, for example, through our NASCAR partnership. In the first half, we delivered volume growth ahead of the category and grew share to 2.8%, up from 9

Imperial Brands Half-Year Results the same period last year.

Tuesday, 12th May 2026

Net revenue grew by 20%, excluding the impact of the Zone

promotional activity over the year-end that Murray mentioned earlier.

So, a positive

performance in the US. Slide - Modern Oral: Consumer-led Product Innovation Growing volume in the US and Europe We are equally excited about the development of our European modern oral business.

In

Europe, our product portfolio is led by our European variant of Zone and the well-established Skruf brand. In the first half, we launched an improved pouch format and new flavours in Sweden. In Norway, Skruf is now the biggest brand. And as you heard and saw at our fullyear results in November, we have also launched Zone in the UK. Here, we have now reached 3% share in the independent channel, where we focused our initial launch, and we are now rolling it out across national accounts. Slide - Vapour: blu Brand Trusted by Consumers Gaining share across footprint driven by blu kits Now, turning to vapour. In the first half, we saw share growth of 130 basis points across our footprint. Our investment is focused on Europe, and we are growing share across many of our major markets in the region. In particular, we saw strong growth in the UK and France, where our rechargeable blu kits are capturing share. You will remember, both those markets banned disposable devices last year. Slide - Heated Tobacco: Showing Consistent Growth Clear consumer focus In heated tobacco, we are growing share across all our markets. This broad-based success has been underpinned by positive consumer response to our Pulze 3.0 device, launched in the second half of last year. Our iSenzia flavoured herbal sticks continue to perform well. We have refreshed our range of tobacco-based sticks to ensure it fully addresses the needs of our target consumer: adult cigarette smokers transitioning into the category. I look forward to providing you with further updates at our full-year results. Slide - Consumer-centric Innovation Leveraging brand building framework to build brand equity So, I've covered the strategic priorities, how we are driving sustainable value in combustibles and building scale in NGP. Now, I want to turn to the strategic enablers, the key elements of our plan that help us deliver consistent top- and bottom-line progress, both now and in the future. I believe our distinctive challenger approach to consumer insights, brand building and innovation is a key source of our success.

Many of you will have heard Paola, our Chief

Consumer Officer, outline our philosophy at last year's CMD. It is about getting as close as possible to our target consumers, creating differentiated brands which meet their needs, and then innovating in a focused way to address their pain points. Over the past six months, we have continued to embed this way of working, and it is delivering measurable progress. And you can see here on the slide a selection of our most recent brand activities and their positive impact on our commercial success.

10

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

In combustibles, our Davidoff, West and the DFX line extensions are helping to drive share, offering greater choice for premium smokers. Innovation in our iconic Backwoods brand with the True Wraps range is driving share in this emerging high-growth segment. In modern oral, we have introduced a range of innovations carefully targeted at priority consumer segments. Slide - Becoming A Data-led & Efficient Organisation Strong momentum behind our transformation agenda As I said earlier, we are focused both on self-help activities to drive efficiency and investment in capabilities to drive revenue growth. In terms of efficiency, on the left, we are well on track to deliver the £320 million of annual savings by the end of the strategic period, a commitment we made at the CMD. In particular, we are making good progress on the rationalisation of our factory footprint. In our Langenhagen factory in Germany, we have now completed the social plan negotiations with colleague representatives, and we are on track to cease production in July 2027. Last week, we announced the sale of our factory in Taiwan. This process will also be complete by next summer. Taken together, these two actions, when completed, will reduce overheads by £100 million. Alongside these actions, we continue to drive manufacturing excellence across our remaining factories, improving quality and delivering further efficiencies of £25 million in fiscal year '26. At the same time, we are making progress in delivering operational efficiencies with a transfer of around 400 roles to our new strategic partner, Capgemini. While efficiency is a necessary element of our transformation, the big differentiator for us is the development of new capabilities to support long-term revenue growth, shown here on the right. The Capgemini partnership will accelerate our adoption of technology, simplify our processes, and provide new consumer capabilities, and in turn, help us capture new commercial opportunities. The partnership will also support delivery of projects already in flight, such as the continued rollout of our enterprise platforms, including SAP S/4HANA, Salesforce and Blue Yonder. Slide - Another Half of Consistent Delivery Positive start to FY26 and implementation of 2030 strategy So, let me now bring everything together.

We have shown how our consistent financial

performance continues to drive strong cash generation, £2.6 billion over the past 12 months, and this is underpinning consistent capital returns. We have shown that we are well-placed to deliver our planned step-up in financial performance in the second half, and we remain committed to the guidance we have previously given. Furthermore, we have shown you the rapid progress we have made over the past six months in the strategic transformation of our business. This is delivering material efficiencies in the short term and, more importantly, will enable more consistent top-line growth, helping us become an even stronger challenger business. Slide - Reinforcing an Attractive Investment Case Global consumer goods business with attractive valuation We believe this all adds up to an attractive investment proposition.

Operational delivery

translating into revenue growth, profit growth and high single-digit EPS growth, along with strong cash flows, all enables highly sustainable capital returns, including our always-on 11

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

evergreen share buyback. To our shareholders, thank you for your continued support, and thank you all for listening to this presentation. This concludes the presentation, and Murray and myself very much look forward to your questions. I would ask John, please, to moderate and open the Q&A section, please. Thank you.

Q&A John Crosse: Thanks, Lukas. Just before we come to questions in the room, if you're watching us online, hopefully on your screen, you should be able to see where you can type in a question. That'll come through to me in the room, and we can ask that. Similarly, if you're listening on the telephone, you should have been given instructions on how to register a question. We'll give you a reminder as well when we come to the phone lines. So, questions in the room, if you could give your name and where you're from, just for people listening on the webcast, in case they can't see. Let's start with Faham in the front row. Faham Baig (UBS): Thanks, guys, for the presentation. Two for me. If I look at your guidance historically on EBIT growth, it's been relatively narrow over the last couple of years, whereas this year, despite seeing the last six months, you've stuck with the 3-5%. I wanted to ask at this stage whether you think the lower half or the upper half of the guidance is likely, or if you can't be as detailed, maybe talking about some of the moving parts that could see you at the upper end or lower end could be quite helpful. The second question is on market share.

It's a two-part question.

Number one, from an

industry volume standpoint, is the situation in terms of volume declines better than where we've been in the past, which allows you to accept slight share losses, is the first part of the question. And the second part of the question is, given this increased focus on more profitable segments, is it better to look at value share compared to volume share as the key metric going forward? Thank you. Lukas Paravicini: Thank you very much, Faham. Let me answer the questions. Hopefully, I don't forget the latter ones. Let me start with the first one, with the guidance. Listen, we have given the first guidance at our Capital Markets Day, which is a 3-5% AOP growth over the next five years. We've reiterated that guidance at the full year. We have delivered a strong performance at the half-year. We have shown you some of the implications that go on top of the normal second half phasing, which is due to pricing increase in the second half, which very nicely showed the over £50 million impact in the first half, which, we believe, will ease in the second half. We're well on track to deliver the full-year guidance. There's really not much more I can say. This is our guidance, and we will deliver within that guidance. So, that's on the guidance. Market share. Let me separate there also between volume and value share. So, indeed, the volumes are doing very well. It's another year where our volumes at half-year are only down 1.5%. Obviously, you have different proportions, different mix. You also have heard that we entered new white spaces, among them Syria, which used to be a big cigarette market and is doing very well. So, that obviously has an impact. Again, we don't guide on volume share, and I would always caution that the long-term trend is 3-5% negative. Every year we're doing 12

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

better. It's great because to get to our target net revenue of 1-2%, we need to price less and that is always helpful for the consumer. So, that's good. So, that's on the volume. Our share discussion and focus on segment is really an evolution. I just want to reiterate how important share is for any company, but share is one of the metrics we look at next to net revenue, operating profit and many other metrics we have.

It's really about this careful

triangulation of price, volume and share in an environment where your gross margin has evolved significantly from the top to the bottom. We will play in all segments because we start with the consumer. Wherever the consumer is, we will be there. But while we double down on the top, we'll also make sure that we are pricing responsibly at the bottom. Now, that's what we're looking at in the market share. To your question, it is a good question: is value share the better one? Listen, we've done this now for the last 30 years. Value share has its benefits, has also its downsides, the same as volume share. In our industry, value share is more difficult to calculate. We don't have the means and the data to do that. Any focus on value or volume share will always lead to a narrow view. That's why it is more important for us actually, rather than seeing whether we switch to value share, to focus on the triangulation of volume, price and share. Sorry for the longer explanation, but I thought it might be useful. John Crosse: Thank you. Next one - Pallav Pallav Mittal (Barclays): Pallav Mittal from Barclays. Two for me, please. Given the new FDA guidance on enforcement priorities in the US and your plan to exit the blu business, how should we think about your NGP strategy going forward, specifically in the US? Do you have any products in the pipeline that you can launch quickly on nicotine pouches or vapour? That's the first one. And then secondly, on the German market, on the tax environment, there seems to be – the five-year plan is coming to an end, and there seems to be a plan to increase the taxes significantly. So, how should we think about your plans in the German market going forward? Lukas Paravicini: Thank you very much, Pallav. I'll take the NGP points and then Murray will answer your questions on the German tax environment. Firstly, we remain very pleased with the performance of our NGP business. We are here to build scale in NGP. We have done so over the last five years, building a strong base, and we have committed to a double-digit growth for the next few years, and we are on track to deliver on the full year. Now, specifically in the US, indeed, you have seen recently new FDA guidance; especially, there's been a flurry of new guidance and comments, especially last week. There was one on Friday, which we would not want to comment on at this stage because the FDA has committed to further clarification probably today or throughout these days. So, we will want to wait until the FDA has made further announcements to that. What is important for us is that, in general, we welcome scientific-based approaches and approaches that actually allow adult smokers easier access to responsible products. In that way, we very much welcome the FDA's effort and genuine interest in reducing the backlog and accelerating the process. That is helpful for all players and is welcome, especially for our consumers.

13

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Now, we are still and remain very excited with the US in terms of OND. We have mentioned to you that, excluding the promotional activity that Murray mentioned, we have grown 40% in volume ahead of the category growth. We have grown 20%, and we're committed to the second half, because we do have grandfathered rights and opportunities in products with stronger strengths and new flavours. So, we have a pipeline of innovation that will allow us to deliver on the second half and beyond. So, very excited with that prospect. And finally, to comment on our vape blu decision, which is very separate to the FDA announcement. Our myblu product is a ten-year-old product. It's an ageing product, which probably does not meet the consumer needs of today, has been making a very limited contribution to the business, and was loss-making. So, that's the reason we have transitioned out, while we look into what we can do in the future. I will keep you informed of that. So, that's on the NGP. And Murray, on Germany. Murray McGowan: Germany. Look for context. So, Germany is a market where it's typically a very predictable tax environment. So, every five years, the government republishes the tax plan for the next five years, which makes it, from our perspective, a very well-managed market. You're right, the government's going through negotiation of the next five-year tax plan. I would say it's a market where there's always very positive engagement with the industry around the evolution of that plan. We engage particularly with the finance ministry in Germany. Now, you would have seen in the press, there were some suggestions recently of an increase in tax to support people in Germany with some of the rising fuel costs. It's clear that has met some opposition in terms of the initial proposals and is going through discussions just now. Our current view is that's highly unlikely to impact this financial year, and any changes may well be folded into the next five-year tax plan. So, we continue to positively engage with the ministry around that, but it's still uncertain as to how it will end, but our expectation is anything would probably be an FY27 and onwards impact. John Crosse: Okay. Great. Thank you. James, there? James Edwardes Jones (RBC): Sorry, James Edwardes Jones from RBC. Could I come back to the market share point, accepting your point that it's actually difficult to calculate value market share? Do you have some idea of value market share trends in the five priority markets that you could share with us? Lukas Paravicini: So, we do – so, it is more complicated than what you would expect, but obviously, we look at what we can get in terms of data, which we currently are not sharing externally because we were focussing on the volume share. But I would step back, James, from that specific volume versus value share. The nature of us looking at share volume and price, you to some extent do exactly that, actually consider the value of your share point. I mean, the point I was making before, the reason we are more fine-tuning our approach to market share, being present in all three segments, but also looking at pricing is because, as I mentioned before, not every bps of volume share is equal. The way you look at that is through the gross margin price length, which is nothing other than an alternative way to look at it from a value share perspective.

14

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

John Crosse: Is that it, James? Do you have another one? I thought you said that was the first one of many. No, it's so unique for a sell-side to ask one single question. I was slightly taken aback by that. Andrei, do you want to go next? Andrei Andon (Jefferies): Hi, good morning.

This is Andrei Andon from Jefferies.

Two

questions for me, please. Number one, how do you see the A&P needs of the NGP business evolving in H2, particularly given the news about the FDA potentially tolerating the sales of some pouch brands without authorisation in the US market, which could increase the competitive intensity kind of near- to mid-term?

And then secondly, there's been growing

discussion about US illicit e-vape enforcement improving. Could you perhaps give more colour on how significant of a tailwind this has been in US combustibles in H1, so for the combustibles business? And then, do you see this tailwind perhaps persisting into H2? Lukas Paravicini: Sorry, Andrei, I missed the first part. What were you looking for in the second half due to the FDA regulation? Andrei Andon: The A&P needs of the NGP business in the US. Lukas Paravicini: Excellent. So, as I said before, we welcome in general all the efforts of the FDA going in the direction of reducing backlog and accelerating the process. Our plans for the second half, and we are very committed to building long-term, patiently, a business in the US around the OND, and we're making good progress. You've seen that in the first half. As I mentioned before, we have plans around strengths and flavours that we are going to support. Those meet our consumer needs, and we start with the consumer. We focus on the consumer. In our budget, we have sufficient A&P considered for what we are needing to do in the second half. And trust me, I mean, you've seen the competitive intensity in the past, which is already very high. Even then, with our very focused approach on our consumers, we have been able to continue to expand our share. The second one is vape and illicit. So, yes, we've always commented that the volumes are driven by four things in the US, which is mainly your secular exit of the category, your crosscategory exit, so meaning you go from cigarettes to vape or something else, in this case often illicit vape, your pricing, and macroeconomics impact. We've always highlighted that actually the bigger impact when the volumes were above 8% would be the decrease of the macroeconomic impact and separately the illicit, actually both in the same way. You've seen that our volumes have improved, the industry volumes have improved in the US, which is great news, which means that we go back to that normality, which some of you doubt that we will get back to. And if you look at the data underneath it, the two drivers there are equally, again, the illicit vape and the macroeconomic impact, meaning that we see the enforcement, while not perfect, while probably not taking away the illicit, has made a dent in the volume declines. It makes a difference. If you listen to the US government, and you see the actions, I have no doubt that that will continue in the second half. You've also seen, and I can't tell you what the impact is of the Middle East crisis on the US consumer sentiment, but you have seen an increased improvement in the consumer sentiment. In fact, it is remarkable to see how strong the US economy is still doing after three months of the Middle East crisis. That trickles down into better volumes as well. We would expect this to continue in the short term.

15

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

John Crosse: Okay. Just going to go to online and then I'll come back into the room. David Roux from Morgan Stanley has just asked two questions online. The first one is, following on from that, at what point does the Middle East conflict impact FY26 guidance? Probably one for you, Murray.

And then the second one is, can you give some more detail about progress

towards getting double duty drawback benefit?

What still needs to happen to become

compliant? How should we think about timing and magnitude? Lukas Paravicini: Do you want to take the fiscal year '26? Murray McGowan: Yeah. I'll talk to it. Well, thanks for the question, David. Look, as I said during the presentation, we haven't seen a meaningful impact of the Middle East crisis to date. Clearly, if you look out into the future, we see potential impact across the areas. So one would be input costs. The reality for us during the course of FY26, we expect minimal impact on input costs, given the amount of fixing we've got in some of our supply coming in for the balance of the year. If it goes on long term through FY27, actually, we'd expect to see some impact through that. Second is duty-free. There are reduced volumes in duty-free in the Middle East airports. So, clearly, there's fewer people going through that.

From a group perspective, that's largely

manageable as we look across this year. The third is – and this is the unknown – is the consumer impact. What we haven't seen so far is a real shift in consumer buying habits. So, with higher gas prices at the pump in the US and other markets, at some point that could impact the consumer buying habit, whether they buy less often, whether more move into illicit or whether they buy cheaper products. We haven't seen it so far. That's the unknown for us at this point in time. So, I can't give you a date, at which suddenly it becomes a problem for us. I haven't seen the impact so far. We monitor it very closely, but at this stage, we are confirming our guidance for the full year. Lukas Paravicini: I think if I may, just before I go to the duty drawback, the Middle East crisis is one of many crises we are going through again. I think all of our consumer peers will look at what happens to the consumer sentiment in months to come. Right now, as Murray said, there's no impact and we are well on track to deliver fiscal year '26. I would also draw your attention to the past. We will continue to be monitoring the situation. We'll surely not be complacent. And we will hopefully be as resilient as in the past. Think about Ukraine. Think about the Red Sea crisis, the hyperinflation. We've been tested, and we have shown that this industry and this company is resilient to crisis.

So, we'll continue to monitor and react to

whatever comes in the future. Duty drawback. Duty drawback, with the clarity we have obtained in August, we are working expeditiously on setting up a duty drawback system, leveraging our global presence. That is not the challenge. The challenge is to get this done in a way that is approved by the FDA. So, we need to approve factories or sites abroad for it to be certified to import into the US. We're well on track, but it takes time. We expect a meaningful contribution of that scheme in fiscal year '26, most likely towards the second half of – excuse me, thank you for clarifying, '27. I'm ahead of my time. Fiscal year '27, just to clarify. So most likely in the second half of '27 and then the full impact in fiscal year '28. John Crosse: Let's go back in the room. Damian, do you have it? 16

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Damian McNeela (Deutsche Bank): Thank you. Damian McNeela at Deutsche Bank. Two, please. First one on US vape. You obviously pulled out and you sort of said you're watching the marketplace. Can you give us some insights into what you're specifically looking for, for perhaps a market re-entry into US vape? And then secondly, perhaps the category is clearly growing globally, but you're only in seven markets.

Are you actively looking at additional

markets to roll out Zone or Skruf into, please? Lukas Paravicini: Thank you, Damian.

Listen, we are a challenger market – we are a

challenger company. And as such, we will always look where we can use the best – where we get the best return for our investments. Clearly, when you look at NGP, the OND business in the US is highly attractive, and we're well on track to continue to expand our presence and our share. When it comes to vape, our biggest markets or regions is Europe, where we have 80% of our business in NGP, and we're growing rapidly. We expanded vape share by 130 bps this half-year.

So, in the US, you have one, the PMTA process, which is still a lengthy, costly

experience, and you still have a big illicit market. So, if I have to make choices right now, we are focussing on the OND markets, where we have products, we have innovation in the pipeline that we can excite our consumers. We will continue to look at the vape markets and at the right time, we'll see what we can do to come back. Pouches. So, you know, the NGP business is an attractive business, but we are very disciplined in how we look at the NGP business. We will build patience in our business, we have committed to a double-digit growth, but we are not going to create the market. As much as I understand the excitement in many markets about pouches, when you look at data, and remember, we are a consumer-first and data-driven company, the data is showing that the markets are very small. And hence, as the fourth largest in the industry and a responsible player also in regards to our shareholders, we will double down on those markets where we have a business or where the market has been created, and we have a route to market.

We shine our effort in Eastern

Europe, where we have our heated tobacco, we have launched Zone in the UK. We might launch it in one or two other markets, but it will be a very measured launch, because what we don’t want, is not to be everywhere a little bit, but we want to double down in those markets where there is a market, and we have a good understanding of our consumer, and we can reach them easily. John Crosse: Okay, thanks. Any other questions in the room? Emma, can we just go quickly on the phone line. Can you give a reminder for people there who want to register a question perhaps? Operator: Thank you. To ask a question, you need to press star one and one on your telephone and wait for your name to be announced. I'll hand back to you, John. John Crosse: Thank you. That prompt has reminded Simon at Citi to register. So, Simon, do you want to go ahead and ask your question? Simon Hales (Citi): Thanks. Morning. Also, a latecomer to the party. My first question was just around the AAACE region, really. Could you talk a little bit more about the combustibles volume performance in the first half, maybe excluding Australia? How much of a volume benefit did you see from the innovation you've put in there, as well as the new market launches, was there some pipeline fill? And how do we think about the volume outlook in that region in the second half of the year for combustibles specifically? 17

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

And then secondly, I may have missed it, but you highlighted sort of, Lukas, in your remarks around the strong start you made on the transformation journey, you've highlighted the factory closures that are underway. How big, though, were the efficiency savings in the first half? Should we expect a step-up to those savings rates in the second half of the year? Or is it really about 2027 is the year that we really see those big benefits starting to flow through? Lukas Paravicini: Thank you, Simon. And Murray, will you take the volumes in AAACE and I'll do transformation? Murray McGowan: Yes, Lukas. On AAACE, I think, Simon, it's important. AAACE has a couple of different drivers that are really supporting volume performance there. So, clearly, as you highlight, we've seen a drop in volumes in Australia.

I think it's important to understand

Australia from a group perspective is a very small amount of volume. I think it's less than 2% of our net revenue sits in Australia. And AAACE has a couple of drivers that are really supporting volume growth. So, one is Africa has a really good strong performance again. So, we see good volume performance across that continent. And then the new market launches. So, Syria will have a meaningful contribution for us, a meaningful contribution in the first half. And again, will step up in the second half. So, it'll help push strong performance within AAACE volume as we go into the second half in combustibles. So, we don't guide on volumes, per se, but I think that trend you see in volume will continue into the second half for those reasons. Lukas Paravicini: Thank you very much. And Simon, thank you very much for asking about the transformation. We are excited about doing two things: performing in the short term but also making sure that we can continue to perform in the long term by transforming our business. And you know, it is equally transforming in the short term and the long term. Short term is we are delivering self-help efficiencies very clearly. I've given you data points like fiscal year '26, we are looking into our factories, how to run them more efficiently, how to apply an operating model that really is consistent with what you see out there. It will deliver £25 million this year and more to come in the following years. We are looking at the factory footprint. We have exited two entities which will cease production by summer '27. That will deliver £100 million progressively until we finish those transformations. So, again, we are well on track and quick out of the blocks when it comes to the £320 million efficiency savings that we have committed. There's no doubt about that. But efficiency is important to us, because without efficiency, you cannot really be effective. But the distinctive thing in our transformation is we don't just stop at the efficiency. We want to go beyond the efficiencies. Because we believe with our strategic partnership with Capgemini, efficiency is a given. But what is really more interesting to us is how we can transform the business to be closer to our consumer, to build on the sales capabilities, tapping into the knowledge and technology that Capgemini has to grow revenue in the future. And I think that combination of short-term self-help efficiency, which will be progressively increasing over the next few years, and that better readiness to deliver also beyond 2030 revenue growth, is really what is distinctive in this transformation. John Crosse: Okay. Thanks for that, Simon. Okay. I think there's nothing else online or on the phone. So, I think I'll bring it to a close. Thanks, everyone, for joining us. Lukas, I'll hand it back to you. 18

Imperial Brands Half-Year Results

Tuesday, 12th May 2026

Lukas Paravicini: Thank you very much. Thank you. I know you've got lots of presentations. So, I really appreciate you showing up and connecting online and showing interest in our company. I hope you have taken three things away from today. One is that we have delivered a good performance in the first half. We have grown our net revenue, our operating profit, and we have delivered yet another six months of very strong cash generation. I hope you leave this room and this online presentation with strong confidence that we are well on track to deliver on the full-year guidance. And thirdly, I hope you can see that we are not just performing today. We're making sure that we are transforming for tomorrow. We're delivering self-help efficiencies in a meaningful way, and we're building the future in a way that we can continue to drive sustainable growth in the future. Thank you very much, and I'll keep seeing you soon. Thank you. [END OF TRANSCRIPT]

19

Full-screen source Call document